← Leaderboards
Linda S Musil
Oregon Health And Science University
$6,068,048
Attributed
$6,068,048
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $385K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,068,048 · 4
By mechanism
R01$6,068,048 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Growth Factor”
- Barton F Haynes · Duke University$92,250,940
- Leonardo Trasande · New York University School Of Medicine$80,868,695
- Lee Hamm · Tulane University Of Louisiana$73,865,452
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$71,795,008
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Margaret Rita Karagas · Dartmouth College$41,711,276
Research focus
Growth FactorLensCellsCataractGap JunctionsIn VivoSerumSignal TransductionMediatingVisionComplicationFiber CellInhibitor/AntagonistOperative Surgical ProceduresAnteriorPathway InteractionsSmall MoleculePreventCombatCataract ExtractionLens FiberNational Eye InstituteExcisionCell Culture System
Grant awards (19)
New strategies for prevention of posterior capsule opacification$373,450
R01 · FY2022 · EY · contact PI
New strategies for prevention of posterior capsule opacification$373,450
R01 · FY2021 · EY · contact PI
New strategies for prevention of posterior capsule opacification$385,000
R01 · FY2020 · EY · contact PI
New strategies for prevention of posterior capsule opacification$385,000
R01 · FY2019 · EY · contact PI
New strategies for prevention of posterior capsule opacification$385,000
R01 · FY2018 · EY · contact PI
TGFB signaling as a therapeutic target in cataract and PCO$377,300
R01 · FY2014 · EY · contact PI
TGFB signaling as a therapeutic target in cataract and PCO$365,750
R01 · FY2013 · EY · contact PI
TGFB signaling as a therapeutic target in cataract and PCO$385,000
R01 · FY2012 · EY · contact PI
Regulation of Lens Cell Coupling and Differentiation$385,000
R01 · FY2010 · EY · contact PI
Regulation of Lens Cell Coupling and Differentiation$385,000
R01 · FY2009 · EY · contact PI
Regulation of Lens Cell Coupling and Differentiation$292,062
R01 · FY2007 · EY · contact PI
Regulation of Lens Cell Coupling and Differentiation$293,708
R01 · FY2006 · EY · contact PI
Regulation of Lens Cell Coupling and Differentiation$300,776
R01 · FY2005 · EY
Regulation of Lens Cell Coupling and Differentiation$300,776
R01 · FY2004 · EY
CONNEXIN32 MUTATIONS IN CHARCOT-MARIE-TOOTH-X DISEASE$188,750
R01 · FY2004 · NS
Regulation of Lens Cell Coupling and Differentiation$325,776
R01 · FY2003 · EY
CONNEXIN32 MUTATIONS IN CHARCOT-MARIE-TOOTH-X DISEASE$188,750
R01 · FY2003 · NS
CONNEXIN32 MUTATIONS IN CHARCOT-MARIE-TOOTH-X DISEASE$188,750
R01 · FY2002 · NS
CONNEXIN32 MUTATIONS IN CHARCOT-MARIE-TOOTH-X DISEASE$188,750
R01 · FY2001 · NS